This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Maurits den Boer, Ph.D.
Co-Founder and CEO at Abvion
Speaker

Profile

Maurits den Boer is co-founder and CEO of Abvion, an Utrecht University spin-off advancing serological antibody discovery by proteomics. With a background in biotechnology, he earned a PhD on "Exploring Humoral Immune Responses by Mass Spectrometry”. His research focused on characterizing antibody structures, interactions, and repertoires using native and top-down mass spectrometry, enabling innovative approaches for therapeutic antibody development.